News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,649 Results
Type
Article (8262)
Company Profile (108)
Press Release (266279)
Multimedia
Podcasts (1)
Webinars (5)
Section
Business (82992)
Career Advice (647)
Deals (16873)
Drug Delivery (6)
Drug Development (37854)
Employer Resources (49)
FDA (5281)
Job Trends (5783)
News (144044)
Policy (11382)
Tag
Academia (733)
Accelerated approval (2)
Allergies (37)
Alliances (21414)
ALS (42)
Alzheimer's disease (550)
Antibody-drug conjugate (ADC) (50)
Approvals (5353)
Artificial intelligence (90)
Autoimmune disease (12)
Automation (6)
Bankruptcy (112)
Best Places to Work (5022)
BIOSECURE Act (3)
Biosimilars (40)
Biotechnology (76)
Bladder cancer (48)
Brain cancer (13)
Breast cancer (105)
Cancer (973)
Cardiovascular disease (57)
Career advice (568)
Career pathing (11)
CAR-T (54)
Cell therapy (154)
Cervical cancer (4)
Clinical research (32373)
Collaboration (374)
Compensation (327)
Complete response letters (6)
COVID-19 (701)
CRISPR (12)
C-suite (116)
Cystic fibrosis (33)
Data (1131)
Depression (21)
Diabetes (96)
Diagnostics (1714)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (41)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (49)
Earnings (36283)
Editorial (4)
Employer branding (6)
Employer resources (46)
Events (46977)
Executive appointments (361)
FDA (5910)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (288)
Gene editing (25)
Generative AI (6)
Gene therapy (81)
GLP-1 (207)
Government (1078)
Grass and pollen (1)
Guidances (72)
Healthcare (5938)
Huntington's disease (6)
IgA nephropathy (13)
Immunology and inflammation (28)
Indications (17)
Infectious disease (739)
Inflammatory bowel disease (65)
Influenza (14)
Intellectual property (43)
Interviews (107)
IPO (8633)
IRA (6)
Job creations (1012)
Job search strategy (492)
Kidney cancer (5)
Labor market (6)
Layoffs (87)
Leadership (10)
Legal (2555)
Liver cancer (34)
Lung cancer (144)
Lymphoma (72)
Machine learning (3)
Management (19)
Manufacturing (114)
MASH (42)
Medical device (4005)
Medtech (4007)
Mergers & acquisitions (8643)
Metabolic disorders (247)
Multiple sclerosis (36)
NASH (8)
Neurodegenerative disease (25)
Neuropsychiatric disorders (4)
Neuroscience (779)
NextGen: Class of 2025 (2092)
Non-profit (1407)
Now hiring (3)
Obesity (109)
Opinion (48)
Ovarian cancer (31)
Pain (38)
Pancreatic cancer (41)
Parkinson's disease (60)
Partnered (8)
Patents (93)
Patient recruitment (56)
Peanut (18)
People (23149)
Pharmaceutical (38)
Pharmacy benefit managers (1)
Phase I (9588)
Phase II (14498)
Phase III (10864)
Pipeline (741)
Policy (18)
Postmarket research (769)
Preclinical (3590)
Press Release (18)
Prostate cancer (34)
Psychedelics (6)
Radiopharmaceuticals (131)
Rare diseases (132)
Real estate (1950)
Recruiting (21)
Regulatory (8556)
Reports (20)
Research institute (597)
Resumes & cover letters (79)
RSV (9)
Schizophrenia (48)
Series A (47)
Series B (34)
Service/supplier (6)
Sickle cell disease (9)
Spinal muscular atrophy (42)
Sponsored (6)
Startups (1335)
State (1)
Stomach cancer (2)
Supply chain (21)
Tariffs (5)
The Weekly (1)
Vaccines (155)
Venture capitalists (6)
Weight loss (27)
Women's health (3)
Worklife (8)
Date
Today (116)
Last 7 days (482)
Last 30 days (1495)
Last 365 days (15693)
2025 (5654)
2024 (17075)
2023 (19809)
2022 (25009)
2021 (27102)
2020 (24545)
2019 (18792)
2018 (13681)
2017 (13794)
2016 (12222)
2015 (15077)
2014 (11378)
2013 (8627)
2012 (8773)
2011 (8773)
2010 (8242)
Location
Africa (223)
Alabama (26)
Alaska (2)
Arizona (53)
Arkansas (6)
Asia (29066)
Australia (3702)
California (3098)
Canada (913)
China (416)
Colorado (120)
Connecticut (177)
Delaware (89)
Europe (37867)
Florida (434)
Georgia (102)
Idaho (8)
Illinois (211)
India (12)
Indiana (95)
Iowa (6)
Japan (121)
Kansas (63)
Kentucky (10)
Louisiana (6)
Maine (17)
Maryland (360)
Massachusetts (2417)
Michigan (57)
Minnesota (154)
Mississippi (2)
Missouri (37)
Nebraska (8)
Nevada (10)
New Hampshire (16)
New Jersey (1076)
New Mexico (6)
New York (1071)
North Carolina (456)
Northern California (1439)
Ohio (75)
Oklahoma (6)
Oregon (14)
Pennsylvania (622)
Puerto Rico (3)
Rhode Island (18)
South America (322)
South Carolina (3)
Southern California (1206)
Tennessee (21)
Texas (422)
United States (11490)
Utah (81)
Virginia (116)
Washington D.C. (21)
Washington State (192)
West Virginia (1)
Wisconsin (19)
274,649 Results for "suzhou connect biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
May 7, 2025
·
2 min read
Business
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
Connect Biopharma Holdings Limited announced that two of its wholly owned subsidiaries, Connect Biopharma Hong Kong Limited and Suzhou Connect Biopharma Co., Ltd., have entered into an exclusive license and collaboration agreement with Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., to develop and commercialize Connect Biopharma’s rademikibart in Greater China.
November 21, 2023
·
6 min read
Press Releases
Veru Participates in a Virtual Investor KOL Connect Segment
May 8, 2025
·
6 min read
Press Releases
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
March 13, 2025
·
3 min read
Press Releases
Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update
April 1, 2025
·
10 min read
Press Releases
Senti Bio Participates in a Virtual Investor KOL Connect Segment
April 21, 2025
·
5 min read
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
The Health and Human Services Secretary said that he will find and eliminate the cause of autism by September, an idea that suggests how little he knows about the condition.
April 17, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
April 24, 2025
·
7 min read
Press Releases
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
April 2, 2025
·
8 min read
Press Releases
Senti Bio Joins Webull Corporate Connect Service Platform
April 7, 2025
·
6 min read
1 of 27,465
Next
